Background. When to discontinue contact precautions (CP) for patients ( pts) with MRSA remains unresolved and policies vary between hospitals. Our facility considers an MRSA patient positive (+) (and thus remaining in CP) until they have had two active surveillance cultures (ASC) return negative (-) or have undergone successful decolonization therapy.
Methods. From October 2010-March 2014 we prospectively performed admission ASC (and weekly for those with (-) results) on pts known to have been MRSA (+) for at least 1 year to determine the proportion who remained MRSA (+). Characteristics (age, sex, race, hospitalization within the year, presence of a wound or foreign body, receipt of antibiotics, hemodialysis, and residence in a group setting) were collected from a chart review to determine factors associated with persistent carriage.
Results. Over the study period 408 pts with MRSA had an admission ASC done a mean of 1671 days from their first known (+) MRSA culture (range 416 -5668 days). Ultimately, 82 (20.1%) pts in the cohort had MRSA detected during the study. 68 (16.7%) of 408 had a (+) admission ASC. Of the 339 pts who had a (-) admission ASC, 181 (53.4%) had a second ASC culture and 8 (4.4%) were (+) for MRSA. Of the 173 pts who had two (-) ASC, 6 (3.5%) went on to have a future culture (+) for MRSA.
Increased number of days between first known (+) MRSA culture to admission ASC was associated with a lower risk for having MRSA detected during the study (p= 0.04) and having the ASC performed more than 5 years since the first known (+) MRSA culture was associated with the lowest risk (OR 0.45, Conclusion. The proportion of pts with MRSA documented more than a year ago who remained (+) was 20.1% however this significantly decreased over time, particularly after 5 years. Our data also suggest that in the absence of a foreign body and especially among females, CP can be discontinued after one (-) admission ASC.
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